HCRS logo


Back Up one level

The PULSE & CARDIOELECTRICS 2010 congress, which took place July 2-4, 2010, was especially successful this year. Distinguished invited speakers from Greece and abroad participated, providing the latest information from their individual specialties.

International developments in arrhythmias, heart failure, coronary artery disease and cardiac imaging made up the main topics.


  • New horizons in the prevention of thromboembolic episodes in patients with atrial fibrillation.
  • New ways of risk stratification.
  • A new category of drugs that promise, with a simple and specific dosage regimen and without regular measurements of coagulation time, similar efficacy and safety to established types of anticoagulant medication.
  • Special report by speakers from other countries about their personal experience and the state of the art as regards the invasive therapy (ablation) of atrial fibrillation.
  • Report on the testing of a subcutaneous defibrillator device without endocardial electrodes that can be implanted without fluoroscopy.

Heart failure

  • Once again, the usefulness was stressed of cardiac resynchronisation therapy in the treatment of heart failure, which appears to extend to patients in earlier stages of the disease.
  • The role of circulatory assist devices in patients with end-stage heart failure was discussed.
  • Percutaneous aortic valve implantation, after the first encouraging mid-term results, seems to be becoming established as a method of treating high risk patients, while its extension to medium risk patients will be decided based on the results of studies now in progress.

Coronary artery disease

  • The Stent for Life programme. Efforts are being made to apply it in Greece. However, support from the state is also needed.

Cardiac imaging

  • The latest developments in echocardiography were presented, such as three-dimensional echocardiography and its contribution to the study of the mitral valve and right ventricle.
  • Study of the distortion of the myocardium using strain and strain rate techniques.

Back Up one level


Go to top Top of page



Hot Articles

  1. Williams B, Cockcroft JR, Kario K et al. Effects of Sacubitril/Valsartan Versus Olmesartan on Central Hemodynamics in the Elderly With Systolic Hypertension: The PARAMETER Study
    Hypertension. 2017;69:411-420. … more More
  2. Aro AL, Rusinaru C, Uy-Evanado A et al. Syncope and risk of sudden cardiac arrest in coronary artery disease. Int. J. Cardiol. 2017; 231:26-30 … more More
  3. Raaijmakers A, Zhang ZY, Claessens J et al. Does Extremely Low Birth Weight Predispose to Low-Renin Hypertension? Hypertension. 2017; 69:443-449. … more More
  4. McCord J, Cabrera R, Lindahl B et al for the TRAPID-AMI Investigators. Prognostic Utility of a Modified HEART Score in Chest Pain Patients in the Emergency Department.
    Circ Cardiovasc Qual Outcomes. 2017;10:e003101. … more More
  5. Aisu H, Saito M, Inaba S et al. Association of worsening arterial stiffness with incident heart failure in asymptomatic patients with cardiovascular risk factors. Hypertens Res 2017 40: 173-180 … more More
  6. Galløe AM, Kelbæk H, Thuesen L et al. 10-Year Clinical Outcome After Randomization to Treatment by Sirolimus- or Paclitaxel-Eluting Coronary Stents. JACC 2017;69:616-624 … more More
  7. Nielles-Vallespin, S., Khalique, Z., et al. Assessment of Myocardial Microstructural Dynamics by In Vivo Diffusion Tensor Cardiac Magnetic Resonance JACC 2017;69:661-676 … more More
  8. Yeh, R. W., Silber, S., et al. 5-Year Safety and Efficacy of Resolute Zotarolimus-Eluting Stent: The RESOLUTE Global Clinical Trial Program . JACC:Cardiov. Interv. 2017;10:247-254 … more More
  9. Rezkalla, S. H., Stankowski, R. V., et al. Management of No-Reflow Phenomenon in the Catheterization Laboratory. JACC:Cardiov. Interv. 2017;10:215-223 … more More
  10. Mahabadi, A. A., Möhlenkamp, S., et al. CAC Score Improves Coronary and CV Risk Assessment Above Statin Indication by ESC and AHA/ACC Primary Prevention Guidelines.
    JACC: Cardiov. Imag. 2017;10:143-153 … more More

Sign up for our newsletter: